Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125227991 | 12522799 | 1 | I | 20160628 | 20160701 | 20160701 | EXP | CA-ABBVIE-16P-028-1663377-00 | ABBVIE | FRALICK M, JUURLINK D, MAARAS T. BLEEDING ASSOCIATED WITH COADMINISTRATION OF RIVAROXABAN AND CLARITHROMYCIN. CMAJ. 2016 JUN 14;188 (9):669-672. | 65.00 | YR | M | Y | 0.00000 | 20160701 | MD | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125227991 | 12522799 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | Y | UNKNOWN | 50662 | 500 | MG | BID | ||||||
| 125227991 | 12522799 | 2 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | UNKNOWN | 50662 | ||||||||||
| 125227991 | 12522799 | 3 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | UNKNOWN | 50662 | ||||||||||
| 125227991 | 12522799 | 4 | I | RIVAROXABAN | RIVAROXABAN | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 125227991 | 12522799 | 5 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125227991 | 12522799 | 6 | C | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 0 | 650 | MG | |||||||||
| 125227991 | 12522799 | 7 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | DOUBLE STRENGTH | 0 | TABLET | QOD | |||||||||
| 125227991 | 12522799 | 8 | C | TIOTROPIUM | TIOTROPIUM | 1 | 18 UG/D | 0 | |||||||||||
| 125227991 | 12522799 | 9 | C | HEPARIN | HEPARIN SODIUM | 1 | 0 | 5000 | DF | BID | |||||||||
| 125227991 | 12522799 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125227991 | 12522799 | 1 | Oropharyngeal pain |
| 125227991 | 12522799 | 2 | Cough |
| 125227991 | 12522799 | 3 | Dyspnoea |
| 125227991 | 12522799 | 4 | Anticoagulant therapy |
| 125227991 | 12522799 | 5 | Product used for unknown indication |
| 125227991 | 12522799 | 6 | Product used for unknown indication |
| 125227991 | 12522799 | 7 | Antifungal prophylaxis |
| 125227991 | 12522799 | 8 | Product used for unknown indication |
| 125227991 | 12522799 | 9 | Thrombosis prophylaxis |
| 125227991 | 12522799 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125227991 | 12522799 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125227991 | 12522799 | Drug interaction | |
| 125227991 | 12522799 | Haemorrhage intracranial | |
| 125227991 | 12522799 | Subarachnoid haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |